Cargando…

miR-132-3p priming enhances the effects of mesenchymal stromal cell-derived exosomes on ameliorating brain ischemic injury

BACKGROUNDS/AIMS: Mesenchymal stromal cell-derived exosomes (MSC-EXs) could exert protective effects on recipient cells by transferring the contained microRNAs (miRs), and miR-132-3p is one of angiogenic miRs. However, whether the combination of MSC-EXs and miR-132-3p has better effects in ischemic...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Qunwen, Kuang, Xiaoli, Cai, Shuyun, Wang, Xiang, Du, Donghui, Wang, Jinju, Wang, Yan, Chen, Yanyu, Bihl, Ji, Chen, Yanfang, Zhao, Bin, Ma, Xiaotang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322840/
https://www.ncbi.nlm.nih.gov/pubmed/32600449
http://dx.doi.org/10.1186/s13287-020-01761-0
_version_ 1783551717959270400
author Pan, Qunwen
Kuang, Xiaoli
Cai, Shuyun
Wang, Xiang
Du, Donghui
Wang, Jinju
Wang, Yan
Chen, Yanyu
Bihl, Ji
Chen, Yanfang
Zhao, Bin
Ma, Xiaotang
author_facet Pan, Qunwen
Kuang, Xiaoli
Cai, Shuyun
Wang, Xiang
Du, Donghui
Wang, Jinju
Wang, Yan
Chen, Yanyu
Bihl, Ji
Chen, Yanfang
Zhao, Bin
Ma, Xiaotang
author_sort Pan, Qunwen
collection PubMed
description BACKGROUNDS/AIMS: Mesenchymal stromal cell-derived exosomes (MSC-EXs) could exert protective effects on recipient cells by transferring the contained microRNAs (miRs), and miR-132-3p is one of angiogenic miRs. However, whether the combination of MSC-EXs and miR-132-3p has better effects in ischemic cerebrovascular disease remains unknown. METHODS: Mouse MSCs transfected with scrambler control or miR-132-3p mimics were used to generate MSC-EXs and miR-132-3p-overexpressed MSC-EXs (MSC-EXs(miR-132-3p)). The effects of EXs on hypoxia/reoxygenation (H/R)-injured ECs in ROS generation, apoptosis, and barrier function were analyzed. The levels of RASA1, Ras, phosphorylations of PI3K, Akt and endothelial nitric oxide synthesis (eNOS), and tight junction proteins (Claudin-5 and ZO-1) were measured. Ras and PI3K inhibitors were used for pathway analysis. In transient middle cerebral artery occlusion (tMCAO) mouse model, the effects of MSC-EXs on the cerebral vascular ROS production and apoptosis, cerebral vascular density (cMVD), Evans blue extravasation, brain water content, neurological deficit score (NDS), and infarct volume were determined. RESULTS: MSC-EXs could deliver their carried miR-132-3p into target ECs, which functionally downregulated the target protein RASA1, while upregulated the expression of Ras and the downstream PI3K phosphorylation. Compared to MSC-EXs, MSC-EXs(miR-132-3p) were more effective in decreasing ROS production, apoptosis, and tight junction disruption in H/R-injured ECs. These effects were associated with increased levels of phosphorylated Akt and eNOS, which could be abolished by PI3K inhibitor (LY294002) or Ras inhibitor (NSC 23766). In the tMCAO mouse model, the infusion of MSC-EXs(miR-132-3p) was more effective than MSC-EXs in reducing cerebral vascular ROS production, BBB dysfunction, and brain injury. CONCLUSION: Our results suggest that miR-132-3p promotes the beneficial effects of MSC-EXs on brain ischemic injury through protecting cerebral EC functions.
format Online
Article
Text
id pubmed-7322840
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-73228402020-06-29 miR-132-3p priming enhances the effects of mesenchymal stromal cell-derived exosomes on ameliorating brain ischemic injury Pan, Qunwen Kuang, Xiaoli Cai, Shuyun Wang, Xiang Du, Donghui Wang, Jinju Wang, Yan Chen, Yanyu Bihl, Ji Chen, Yanfang Zhao, Bin Ma, Xiaotang Stem Cell Res Ther Research BACKGROUNDS/AIMS: Mesenchymal stromal cell-derived exosomes (MSC-EXs) could exert protective effects on recipient cells by transferring the contained microRNAs (miRs), and miR-132-3p is one of angiogenic miRs. However, whether the combination of MSC-EXs and miR-132-3p has better effects in ischemic cerebrovascular disease remains unknown. METHODS: Mouse MSCs transfected with scrambler control or miR-132-3p mimics were used to generate MSC-EXs and miR-132-3p-overexpressed MSC-EXs (MSC-EXs(miR-132-3p)). The effects of EXs on hypoxia/reoxygenation (H/R)-injured ECs in ROS generation, apoptosis, and barrier function were analyzed. The levels of RASA1, Ras, phosphorylations of PI3K, Akt and endothelial nitric oxide synthesis (eNOS), and tight junction proteins (Claudin-5 and ZO-1) were measured. Ras and PI3K inhibitors were used for pathway analysis. In transient middle cerebral artery occlusion (tMCAO) mouse model, the effects of MSC-EXs on the cerebral vascular ROS production and apoptosis, cerebral vascular density (cMVD), Evans blue extravasation, brain water content, neurological deficit score (NDS), and infarct volume were determined. RESULTS: MSC-EXs could deliver their carried miR-132-3p into target ECs, which functionally downregulated the target protein RASA1, while upregulated the expression of Ras and the downstream PI3K phosphorylation. Compared to MSC-EXs, MSC-EXs(miR-132-3p) were more effective in decreasing ROS production, apoptosis, and tight junction disruption in H/R-injured ECs. These effects were associated with increased levels of phosphorylated Akt and eNOS, which could be abolished by PI3K inhibitor (LY294002) or Ras inhibitor (NSC 23766). In the tMCAO mouse model, the infusion of MSC-EXs(miR-132-3p) was more effective than MSC-EXs in reducing cerebral vascular ROS production, BBB dysfunction, and brain injury. CONCLUSION: Our results suggest that miR-132-3p promotes the beneficial effects of MSC-EXs on brain ischemic injury through protecting cerebral EC functions. BioMed Central 2020-06-29 /pmc/articles/PMC7322840/ /pubmed/32600449 http://dx.doi.org/10.1186/s13287-020-01761-0 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Pan, Qunwen
Kuang, Xiaoli
Cai, Shuyun
Wang, Xiang
Du, Donghui
Wang, Jinju
Wang, Yan
Chen, Yanyu
Bihl, Ji
Chen, Yanfang
Zhao, Bin
Ma, Xiaotang
miR-132-3p priming enhances the effects of mesenchymal stromal cell-derived exosomes on ameliorating brain ischemic injury
title miR-132-3p priming enhances the effects of mesenchymal stromal cell-derived exosomes on ameliorating brain ischemic injury
title_full miR-132-3p priming enhances the effects of mesenchymal stromal cell-derived exosomes on ameliorating brain ischemic injury
title_fullStr miR-132-3p priming enhances the effects of mesenchymal stromal cell-derived exosomes on ameliorating brain ischemic injury
title_full_unstemmed miR-132-3p priming enhances the effects of mesenchymal stromal cell-derived exosomes on ameliorating brain ischemic injury
title_short miR-132-3p priming enhances the effects of mesenchymal stromal cell-derived exosomes on ameliorating brain ischemic injury
title_sort mir-132-3p priming enhances the effects of mesenchymal stromal cell-derived exosomes on ameliorating brain ischemic injury
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322840/
https://www.ncbi.nlm.nih.gov/pubmed/32600449
http://dx.doi.org/10.1186/s13287-020-01761-0
work_keys_str_mv AT panqunwen mir1323pprimingenhancestheeffectsofmesenchymalstromalcellderivedexosomesonamelioratingbrainischemicinjury
AT kuangxiaoli mir1323pprimingenhancestheeffectsofmesenchymalstromalcellderivedexosomesonamelioratingbrainischemicinjury
AT caishuyun mir1323pprimingenhancestheeffectsofmesenchymalstromalcellderivedexosomesonamelioratingbrainischemicinjury
AT wangxiang mir1323pprimingenhancestheeffectsofmesenchymalstromalcellderivedexosomesonamelioratingbrainischemicinjury
AT dudonghui mir1323pprimingenhancestheeffectsofmesenchymalstromalcellderivedexosomesonamelioratingbrainischemicinjury
AT wangjinju mir1323pprimingenhancestheeffectsofmesenchymalstromalcellderivedexosomesonamelioratingbrainischemicinjury
AT wangyan mir1323pprimingenhancestheeffectsofmesenchymalstromalcellderivedexosomesonamelioratingbrainischemicinjury
AT chenyanyu mir1323pprimingenhancestheeffectsofmesenchymalstromalcellderivedexosomesonamelioratingbrainischemicinjury
AT bihlji mir1323pprimingenhancestheeffectsofmesenchymalstromalcellderivedexosomesonamelioratingbrainischemicinjury
AT chenyanfang mir1323pprimingenhancestheeffectsofmesenchymalstromalcellderivedexosomesonamelioratingbrainischemicinjury
AT zhaobin mir1323pprimingenhancestheeffectsofmesenchymalstromalcellderivedexosomesonamelioratingbrainischemicinjury
AT maxiaotang mir1323pprimingenhancestheeffectsofmesenchymalstromalcellderivedexosomesonamelioratingbrainischemicinjury